STOCK TITAN

KeyCorp Form 4 Filings

KEY NYSE

Every Form 4 that KeyCorp (KEY) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow KEY and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full KEY filings page.

Rhea-AI Summary

KeyCorp executive Angela G. Mago, Chief Human Resources Officer, reported several equity compensation moves involving restricted stock units, stock options, and common shares. On February 16, 2026, she received 18,432 restricted stock units and 19,667 options to buy shares, each vesting in four equal annual installments beginning on February 17, 2027.

On February 17, 2026, she exercised multiple previously granted restricted stock unit awards, converting them into 32,561 common shares. To cover tax obligations, 12,412 common shares were disposed of at $21.69 per share through a tax-withholding transaction, leaving her with 281,564 common shares held directly. Footnotes explain that each restricted stock unit equals one common share at vesting and note additional dividend-equivalent units accrued in prior periods.

Rhea-AI Summary

KeyCorp Chief Financial Officer Clark H. Khayat reported equity compensation activity and related share withholding. On February 16, 2026, he received 31,012 restricted stock units and an option to buy 33,434 shares, each vesting in four equal annual installments beginning February 17, 2027. On February 17, 2026, multiple previously granted restricted stock unit awards were exercised into a total of 26,845 common shares, and 8,130 common shares were disposed of at $21.69 per share to satisfy tax-withholding obligations. Following these transactions, he directly owned 160,059 KeyCorp common shares.

Rhea-AI Summary

KEYCORP Chief Auditor Allyson M. Kidik reported several equity compensation transactions involving company stock. On February 16, 2026, she was granted 5,184 restricted stock units and an option to buy 5,673 shares, both vesting in four equal annual installments beginning February 17, 2027.

On February 17, 2026, multiple restricted stock unit awards were exercised as they vested, resulting in the acquisition of 4,957 common shares, bringing her direct common share holdings to 27,029 before tax withholding. To cover taxes, 1,730 common shares were disposed of at $21.69 per share, leaving 25,299 directly held common shares.

Rhea-AI Summary

KeyCorp Chairman and CEO Christopher M. Gorman reported multiple equity award transactions. On February 17, 2026, he exercised restricted stock units into 130,037 common shares and had 51,080 shares withheld at $21.69 per share to cover tax obligations, leaving 759,081 common shares held directly.

On February 16, 2026, he received grants of 98,156 restricted stock units and an option to buy 107,413 shares, each vesting in four equal annual installments beginning February 17, 2027. He also reports indirect holdings of 200,000 and 250,000 common shares in grantor retained annuity trusts for himself and his children, and 5,251 shares in a 401(k) plan.

Rhea-AI Summary

KeyCorp Chief Accounting Officer Stacy L. Gilbert reported multiple equity compensation transactions. On February 16, 2026, he received grants of 5,529 restricted stock units and an option to buy 6,051 shares, each vesting in four equal annual installments beginning February 17, 2027.

On February 17, 2026, several prior restricted stock unit awards were exercised or converted into a total of 4,279 common shares. To cover tax obligations, there was a tax-withholding disposition of 1,493 common shares at $21.69 per share. After these transactions, Gilbert directly owned 6,280 KeyCorp common shares.

Rhea-AI Summary

KeyCorp executive Kenneth C. Gavrity reported multiple equity compensation transactions. On February 17, 2026, restricted stock units converted into 21,702 common shares, and 6,646 common shares were disposed of to satisfy tax withholding at $21.69 per share, leaving 134,647 common shares directly owned.

On February 16, 2026, he received 43,778 restricted stock units and an option to buy 22,692 shares, each vesting in four equal annual installments beginning February 17, 2027. Each restricted stock unit represents one KeyCorp common share upon vesting.

Rhea-AI Summary

KeyCorp executive Trina M. Evans reported multiple equity award transactions. On February 17, 2026, she acquired 13,094 common shares through exercises or conversions of restricted stock units and options, and 4,078 common shares were disposed of at $21.6900 per share to satisfy tax withholding obligations.

On February 16, 2026, she received grants of 9,677 restricted stock units and 10,590 options to buy KeyCorp shares, each vesting in four equal annual installments beginning on February 17, 2027. Footnotes also describe earlier restricted stock unit grants from 2022–2025 with four-year vesting and additional dividend-equivalent units.

Rhea-AI Summary

KEYCORP Chief Information Officer Amy G. Brady reported multiple equity compensation transactions. On February 16, 2026, she received grants of 20,737 restricted stock units and an option to buy 22,692 shares, each vesting in four equal annual installments beginning on February 17, 2027.

On February 17, 2026, several previously granted restricted stock units were exercised and converted into common shares through transactions coded M, and 27,806 common shares were acquired from derivative exercises. A separate F-coded transaction disposed of 8,413 common shares at $21.6900 per share to cover tax liabilities, leaving 51,915 common shares held directly.

Rhea-AI Summary

KeyCorp Head of Consumer Bank Victor B. Alexander reported multiple equity compensation moves. On February 16, 2026, he received 22,119 restricted stock units and an option to buy 24,205 shares, each vesting in four equal annual installments beginning February 17, 2027.

On February 17, 2026, several earlier restricted stock unit awards were exercised into common shares, and 6,845 common shares were disposed of at $21.69 per share to cover tax obligations. Following these transactions, he directly held 162,458 common shares, plus 2,070 shares by trust and 10,961 shares in a 401(k) plan reported as of February 9, 2026.

Rhea-AI Summary

Bank of Nova Scotia, a director and 10% owner of KeyCorp, reported a disposition of common shares. On February 10, 2026, it disposed of 415,133 KeyCorp common shares at $22.47 per share under an Investment Agreement tied to issuer share repurchases. Following this transaction, Bank of Nova Scotia directly owned 160,907,941 KeyCorp common shares.

Rhea-AI Summary

KeyCorp officer Andrew J. Paine III, Head of Institutional Bank, sold 65,961 KeyCorp common shares on February 6, 2026 in an open-market transaction. The weighted average sale price was $23.23 per share, with individual trades ranging from $23.23 to $23.26.

After the sale, Paine directly beneficially owns 166,583 common shares. He also has indirect ownership interests, including 4,265 shares held by his spouse, 445 shares held by Paine Investments LP, 108,746 shares held by a grantor retained annuity trust, and 26,389 shares in a 401(k) plan reported as of February 9, 2026.

Rhea-AI Summary

Bank of Nova Scotia, a director and 10% owner of KeyCorp, reported selling common shares in a structured transaction. On February 3, 2026, it disposed of 517,633 KeyCorp common shares at $21.36 per share, leaving 161,323,074 shares beneficially owned.

The disposition was made under an Investment Agreement dated August 12, 2024, which allows Bank of Nova Scotia to participate on a pro rata basis, in certain cases automatically, in any repurchase of KeyCorp common shares by the company.

Rhea-AI Summary

KeyCorp’s Chief Human Resources Officer Angela G. Mago reported option and stock transactions dated January 29, 2026. She exercised an option to buy 62,850 Common Shares at $10.49 per share, then sold 62,850 Common Shares in multiple trades at a weighted average price of $21.55, with individual sale prices ranging from $21.54 to $21.55. Following these transactions, she directly beneficially owned 261,415 Common Shares. The filing notes this total includes approximately 4,257 shares that had been inadvertently omitted previously due to an administrative error. The option to buy 62,850 shares, which had vested in four equal annual installments ending on February 17, 2020, now shows 0 derivative securities remaining beneficially owned.

Rhea-AI Summary

Bank of Nova Scotia, a director and 10% owner of KeyCorp (KEY), reported a disposition of common shares tied to KeyCorp’s share repurchase activity. On January 27, 2026, it disposed of 128,055 common shares at $21.16 per share.

After this transaction, Bank of Nova Scotia beneficially owned 161,840,707 KeyCorp common shares, held directly. The filing explains that the disposition occurred under an Investment Agreement, under which Bank of Nova Scotia participates on a pro rata basis, in certain circumstances automatically, in repurchases of KeyCorp’s common shares by the company.

Rhea-AI Summary

KeyCorp director Robin Hayes reported a routine equity transaction. On January 24, 2026, Hayes converted 738 Deferred Shares into 738 Common Shares at a reported price of $0.00 per share under transaction code M (option or derivative exercise).

After the transaction, Hayes directly held 26,461 Common Shares and 59,495 Deferred Shares. Each Deferred Share is described as the economic equivalent of one Common Share, meaning it tracks the same value as the regular stock.

Rhea-AI Summary

KeyCorp Chief Risk Officer Mohit Ramani reported equity compensation activity involving restricted stock units (RSUs) and common shares. On January 23, 2026, 61,483 RSUs were converted into 61,483 KeyCorp common shares at an exercise price of $0, increasing his directly held common shares to 71,691 after this transaction. On the same day, 21,097 common shares were disposed of at $21.1 per share in a transaction coded “F,” leaving him with 50,593 common shares held directly. The RSUs were originally granted on January 23, 2025 and vest in two equal annual installments starting January 23, 2026. The filing notes additional common shares and dividend-equivalent RSUs accumulated through dividend reinvestments during 2025.

Rhea-AI Summary

KeyCorp officer Trina M. Evans, listed as Director, Corporate Center, reported an option exercise and share sale. On January 22, 2026, an option to buy Common Shares for $18.96 per share covering 8,695 shares was exercised, converting the derivative position into Common Shares. That same day, 8,695 Common Shares were acquired at $18.96 per share and 32,695 Common Shares were sold in an open-market transaction at a weighted average price of $21.74 per share, with individual trades ranging from $21.73 to $21.78.

After these transactions, Evans directly beneficially owned 58,719 Common Shares of KeyCorp. The filing notes that full details of the number of shares sold at each separate price within the stated range are available upon request.

Rhea-AI Summary

KeyCorp executive Victor B. Alexander, Head of Consumer Bank, reported several equity transactions in KeyCorp common shares. On January 21, 2026, he exercised an employee stock option for 9,345 common shares at an exercise price of $10.49 per share, increasing his direct holdings. On the same date, 6,236 common shares were disposed of in a transaction coded "F" at $21.72 per share, typically used to cover tax obligations on equity awards.

After these transactions, Alexander directly owned 146,171 common shares, and indirectly held 2,070 common shares through a trust and 10,970 common shares in a 401(k) plan, reported as of January 22, 2026. The option to buy 9,345 shares, which had vested in four equal annual installments ending on February 17, 2020, was fully exercised and the derivative position reduced to zero.

Rhea-AI Summary

KeyCorp director reports deferred share distributions and holdings update. On 01/01/2026, a KeyCorp director converted deferred shares into common shares in two transactions. The director acquired 1,526 common shares and 1,377 common shares through the exercise of deferred share rights that are the economic equivalent of common shares under the KeyCorp Second Directors' Deferred Compensation Plan and related arrangements.

Following these transactions, the director beneficially owned 77,787 and 79,164 common shares in direct form, as well as 10,683 and 178,885 deferred shares. The filing notes these amounts include dividend reinvestments and dividend-equivalent deferred shares credited in December 2025, and that certain deferred shares will be distributed in ten quarterly installments beginning on July 1, 2025.

Rhea-AI Summary

KeyCorp director Todd J. Vasos reported equity holdings and a compensation-related share deferral. As of a transaction dated 12/31/2025, he held 35,255 KeyCorp common shares directly. In addition, he acquired 1,574 deferred shares under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan, at a reference price of $20.64 per deferred share.

The deferred shares are described as the economic equivalent of common shares, with payment deferred until the earlier of January 1, 2027 or the director's death. Following this transaction, Vasos held 65,087 derivative securities tied to common shares, which include approximately 630 dividend-equivalent deferred shares that accrued in December 2025.

Rhea-AI Summary

KeyCorp director reports share disposition and deferral of fees into stock-based compensation plan. A KeyCorp director reported a transaction dated 12/31/2025 involving 750 common shares disposed of. The director also acquired 1,453 deferred share units at a reference price of $20.64, each economically equivalent to a KeyCorp common share, under the company’s Amended and Restated Directors' Deferred Share Sub-Plan to the 2019 Equity Compensation Plan.

Following these transactions, the director beneficially owned 76,711 derivative securities in the form of deferred shares. Payment of these deferred shares has been postponed until the earlier of January 1, 2027, or the director’s death, and this total includes approximately 747 dividend-equivalent deferred shares accrued in December 2025.

Rhea-AI Summary

KeyCorp director reports equity award activity involving deferred shares and common stock. On 01/01/2026, the reporting person converted 8,635 Deferred Shares into 8,635 Common Shares, resulting in 59,506 Common Shares beneficially owned directly after this transaction. On 01/02/2026, an additional 1,703 Deferred Shares were converted into 1,703 Common Shares, increasing direct beneficial ownership to 61,209 Common Shares.

The person also continues to hold derivative positions in Deferred Shares. After the 01/01/2026 transaction, 58,922 Deferred Shares were beneficially owned, and after the 01/02/2026 transaction, 57,219 Deferred Shares remained. Each Deferred Share is the economic equivalent of one Common Share, and the derivative holdings include approximately 2,246 dividend-equivalent Deferred Shares accrued under a Deferred Share Plan between June and December 2025.

Rhea-AI Summary

KeyCorp director Elizabeth R. Gile reported a share conversion on Form 4. On 01/01/2026, 4,319 Deferred Shares were converted (transaction code M) into the same number of KeyCorp common shares. Following this transaction, she directly owned 45,201 common shares.

The report also shows continued ownership of 123,368 Deferred Shares, each of which is the economic equivalent of one common share. This Deferred Share balance includes approximately 4,244 dividend-equivalent Deferred Shares that accrued between June 2025 and December 2025.

Rhea-AI Summary

KeyCorp director Alexander M. Cutler reported an update to his equity holdings in the company. On 12/31/2025, he acquired 1,090 deferred shares under KeyCorp’s Amended and Restated Directors' Deferred Share Sub-Plan, at a reference price of $20.64 per underlying common share. These deferred shares represent directors’ fees that have been converted into the economic equivalent of common shares.

Under the plan, payment of the deferred shares is postponed until the earlier of July 1, 2028 or the director’s death. After this transaction, Cutler beneficially owned 298,416 common shares directly and 56,370 deferred shares, which include approximately 548 dividend-equivalent deferred shares accrued in December 2025.

Rhea-AI Summary

KeyCorp director Devina A. Rankin reported a fee deferral transaction involving deferred share units tied to KeyCorp common shares. On 12/31/2025, Rankin acquired 1,453 deferred shares under the Amended and Restated Directors' Deferred Share Sub-Plan to the KeyCorp Amended and Restated 2019 Equity Compensation Plan at a conversion price of $20.64 per underlying common share. These deferred shares are described as the economic equivalent of common shares, with payment deferred until the earlier of January 1, 2031, or the director’s death. Following this transaction, Rankin beneficially owned 79,346 derivative deferred shares, which includes approximately 773 dividend-equivalent deferred shares accrued in December 2025, and 13,430 common shares held directly.

Rhea-AI Summary

KeyCorp director Robin N. Hayes reported equity award activity. On 01/01/2026, Hayes acquired 3,174 KeyCorp common shares through an option or deferred share conversion shown with transaction code "M," bringing direct beneficial ownership of common shares to 25,723.

In a related transaction, 1,453 deferred shares were credited as of 12/31/2025, each economically equivalent to one common share at a reference value of $20.64 per share. Following these transactions, Hayes beneficially owned 60,233 deferred shares, which include approximately 615 dividend-equivalent deferred shares accrued in December 2025. Under the Deferred Share Plan, payment of these deferred shares is postponed until the earlier of January 1, 2028, or the participant’s death.

Rhea-AI Summary

KeyCorp disclosed that a reporting person who is both a director and a 10% owner disposed of 225,084 common shares on 12/16/2025 at a price of $20.22 per share. After this transaction, the reporting person beneficially owns 161,968,762 common shares directly.

The disposition is described as occurring under an Investment Agreement dated August 12, 2024 between the reporting person and KeyCorp, which provides for the reporting person to participate, in certain circumstances automatically, on a pro rata basis in any repurchase by KeyCorp of its common shares. For Section 16 purposes, the reporting person may be deemed a director-by-deputization because of its contractual right to nominate directors to KeyCorp’s board.

Rhea-AI Summary

KeyCorp officer reports gifted share transfer and updated holdings

A senior KeyCorp officer, listed as Head of Institutional Bank, reported a Form 4 transaction involving KeyCorp common shares. On 12/10/2025, the reporting person transferred 12,500 KeyCorp common shares as a gift at a price of $0, which is classified as a disposition. Following this transaction, the officer directly owns 232,544 KeyCorp common shares. The filing also notes additional indirect holdings, including shares held through Paine Investments LP, the officer's spouse, a grantor retained annuity trust for the benefit of the officer and the officer's children, and a 401(k) plan.

Rhea-AI Summary

KeyCorp insider reporting a director and 10% owner filed a Form 4 showing a sale of common shares. On 12/09/2025, the reporting person disposed of 100,316 KeyCorp common shares at $18.86 per share. After this transaction, the reporting person beneficially owned 162,193,846 common shares in direct form.

The disposition is described as occurring under an Investment Agreement dated August 12, 2024, which allows the reporting person to participate on a pro rata basis in certain repurchases of KeyCorp common shares by the company. For Section 16 purposes, the reporting person may be deemed a director-by-deputization due to its contractual right to nominate directors to KeyCorp’s board.

Rhea-AI Summary

KeyCorp (KEY) reported an insider share disposition by a major shareholder and director-level affiliate. On 12/02/2025, the reporting person disposed of 57,241 common shares at a price of $18.29 per share. Following this transaction, the reporting person beneficially owned 162,294,162 KeyCorp common shares.

The sale occurred under an Investment Agreement between the reporting person and KeyCorp, which provides for the reporting person to participate, in certain circumstances automatically, on a pro rata basis in any repurchase by KeyCorp of its common shares. The filing also clarifies that this ownership figure excludes certain "Excluded Shares" held on a proprietary basis in which the reporting person has no pecuniary interest, and notes that the reporting person may be deemed a director-by-deputization under this agreement.

Rhea-AI Summary

KeyCorp (KEY) reported an insider transaction by a reporting person who is both a director and 10% owner. On 11/18/2025, the reporting person disposed of 214,129 common shares at a price of $17.87 per share. After this sale, the reporting person beneficially owned 162,783,583 common shares, held directly.

The disposition was made pursuant to an Investment Agreement dated August 12, 2024, under which the reporting person participates, in certain circumstances and on a pro rata basis, in any repurchase by KeyCorp of its common shares. For Section 16 purposes, the reporting person may be deemed a director-by-deputization because of its contractual right to nominate directors to KeyCorp’s board.

Rhea-AI Summary

KeyCorp (KEY) reported an insider transaction by a director. On 10/01/2025, deferred share units were distributed into common stock under the company’s deferred compensation arrangements, resulting in acquisitions of 1,493 and 1,363 common shares. Following these transactions, the director beneficially owned 76,126 common shares directly. A portion of the total includes approximately 146 common shares acquired via dividend reinvestments in September 2025.

The filing also shows continuing derivative balances of deferred share units, which are economically equivalent to common shares: 12,089 deferred shares (including approximately 147 dividend-equivalent deferred shares accrued in September 2025) and 178,474 deferred shares (including approximately 1,936 dividend-equivalent deferred shares accrued in September 2025). Certain deferred shares are scheduled to distribute in ten quarterly installments beginning on July 1, 2025.

Rhea-AI Summary

Todd J. Vasos, a director of KeyCorp (KEY), reported transactions dated 09/30/2025. The filing shows a disposition of 35,255 common shares (non-derivative) and the acquisition of 1,738 deferred shares under the KeyCorp Deferred Share Plan converted from deferred director fees at an effective price of $18.69 per share. The report states that approximately 658 dividend-equivalent deferred shares were included in September 2025. Payment of deferred shares is scheduled for the earlier of January 1, 2027 or the participant's death. The Form 4 was signed by a POA, Adam J. Larkins, on 10/02/2025.

Rhea-AI Summary

Devina A. Rankin, a KeyCorp (KEY) director, reported transactions on 09/30/2025 showing a sale of 13,430 common shares and the acquisition of 1,605 deferred shares under the company’s Amended and Restated Directors' Deferred Share Sub-Plan. The deferred shares represent fees directors elected to defer and are the economic equivalent of common shares; they are payable the earlier of January 1, 2031 or the participant’s death. The filing reports total beneficial ownership of 77,121 common shares following the transactions and notes approximately 813 dividend-equivalent deferred shares accrued in September 2025. The Form 4 was signed by a power of attorney on 10/02/2025.